These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 17143262)

  • 1. Increased expression of stem cell markers in malignant melanoma.
    Klein WM; Wu BP; Zhao S; Wu H; Klein-Szanto AJ; Tahan SR
    Mod Pathol; 2007 Jan; 20(1):102-7. PubMed ID: 17143262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue microarray analysis of ezrin, KBA.62, CD166, nestin, and p-Akt in melanoma versus banal and atypical nevi, and nonmelanocytic lesions.
    Shanesmith RP; Smart C; Cassarino DS
    Am J Dermatopathol; 2011 Oct; 33(7):663-8. PubMed ID: 21915031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic utility of neural stem and progenitor cell markers nestin and SOX2 in distinguishing nodal melanocytic nevi from metastatic melanomas.
    Chen PL; Chen WS; Li J; Lind AC; Lu D
    Mod Pathol; 2013 Jan; 26(1):44-53. PubMed ID: 22899289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immuno-expression of human melanoma stem cell markers in tissues at different stages of the disease.
    Sharma BK; Manglik V; Elias EG
    J Surg Res; 2010 Sep; 163(1):e11-5. PubMed ID: 20638684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consistent expression of the stem cell renewal factor BMI-1 in primary and metastatic melanoma.
    Mihic-Probst D; Kuster A; Kilgus S; Bode-Lesniewska B; Ingold-Heppner B; Leung C; Storz M; Seifert B; Marino S; Schraml P; Dummer R; Moch H
    Int J Cancer; 2007 Oct; 121(8):1764-70. PubMed ID: 17597110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of intermedial filament nestin in malignant melanoma progression].
    Brychtová S; Fiurásková M; Brychta T; Hirnák J
    Cesk Patol; 2005 Oct; 41(4):143-5. PubMed ID: 16382989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling of ABC transporters ABCB5, ABCF2 and nestin-positive stem cells in nevi, in situ and invasive melanoma.
    Setia N; Abbas O; Sousa Y; Garb JL; Mahalingam M
    Mod Pathol; 2012 Aug; 25(8):1169-75. PubMed ID: 22555176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the stem cell markers nestin and CD133 on circulating melanoma cells.
    Fusi A; Reichelt U; Busse A; Ochsenreither S; Rietz A; Maisel M; Keilholz U
    J Invest Dermatol; 2011 Feb; 131(2):487-94. PubMed ID: 20882037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-expression of putative cancer stem cell markers, CD133 and Nestin, in skin tumors.
    Sabet MN; Rakhshan A; Erfani E; Madjd Z
    Asian Pac J Cancer Prev; 2014; 15(19):8161-9. PubMed ID: 25339000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of CD133 and other putative stem cell markers in uveal melanoma.
    Thill M; Berna MJ; Grierson R; Reinhart I; Voelkel T; Piechaczek C; Galambos P; Jager MJ; Richard G; Lange C; Gehling UM
    Melanoma Res; 2011 Oct; 21(5):405-16. PubMed ID: 21900792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The stem cell marker nestin predicts poor prognosis in human melanoma.
    Piras F; Perra MT; Murtas D; Minerba L; Floris C; Maxia C; Demurtas P; Ugalde J; Ribatti D; Sirigu P
    Oncol Rep; 2010 Jan; 23(1):17-24. PubMed ID: 19956860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nestin is highly expressed in advanced-stage melanomas and neurotized nevi.
    Akiyama M; Matsuda Y; Ishiwata T; Naito Z; Kawana S
    Oncol Rep; 2013 Apr; 29(4):1595-9. PubMed ID: 23417116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD133 and ABCB5 as stem cell markers on sentinel lymph node from melanoma patients.
    Gazzaniga P; Cigna E; Panasiti V; Devirgiliis V; Bottoni U; Vincenzi B; Nicolazzo C; Petracca A; Gradilone A
    Eur J Surg Oncol; 2010 Dec; 36(12):1211-4. PubMed ID: 20573479
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients.
    Donizy P; Zietek M; Halon A; Leskiewicz M; Kozyra C; Matkowski R
    Diagn Pathol; 2015 Jul; 10():86. PubMed ID: 26134500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer.
    Horst D; Kriegl L; Engel J; Kirchner T; Jung A
    Cancer Invest; 2009 Oct; 27(8):844-50. PubMed ID: 19626493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.
    Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA
    Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of stem cell-like precursor cells from primary human anaplastic oligoastrocytoma.
    Yi L; Zhou ZH; Ping YF; Chen JH; Yao XH; Feng H; Lu JY; Wang JM; Bian XW
    Mod Pathol; 2007 Oct; 20(10):1061-8. PubMed ID: 17660801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation research between cancer stem cells and the pathological grades of neuroepithelial tumors].
    Deng YW; Fang JS; Li MC; Chen FH; Zhou XY; Wu J; Zhou RH; Fang F; Chen C; Lu M; Zeng FY
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):45-51. PubMed ID: 16562674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
    Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
    Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The initial steps of tumor progression in melanocytic lineage: a histochemical approach.
    Wollina U; Kilian U; Henkel U; Schaarschmidt H; Knopf B
    Anticancer Res; 1991; 11(4):1405-14. PubMed ID: 1746897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.